NCT05154058

Brief Summary

Medial subperiosteal release is a commonly performed technique to improve surgical exposure and aid in joint balancing. This is a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) or electrocautery. The intervention will be randomly assigning subjects undergoing TKA into two groups, one receiving subperiosteal release using a scalpel (aka sharp medial peel) and the other via electrocautery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 10, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

November 2, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2023

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

3 months

First QC Date

November 23, 2021

Last Update Submit

October 25, 2023

Conditions

Keywords

Medial Subperiosteal Release

Outcome Measures

Primary Outcomes (3)

  • Change in Visual Analogue Pain Scale (VAS)

    The visual analog scale (VAS) is a tool used to measure pain. Patients will be asked to indicate their perceived pain intensity (most commonly) along a 100 mm horizontal line, and this rating is then measured from the left edge .

    Before and after surgery at the 3 month, 6 month, and 12 month follow-ups

  • Change in Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a 12-item patient-reported outcomes (PRO) specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty)

    Before and after surgery at the 3 month, 6 month, and 12 month follow-ups

  • Change in Incidence of Pes bursitis

    All patients will be seen post-operatively to monitor their progress and minimize risks, and the diagnosis of pes bursitis will be determined through clinical exam.

    3 weeks, 3 months, 6 months, and 12 months post-operatively.

Secondary Outcomes (1)

  • Changes in Varus valgus knee assessment

    3 weeks, 3 months, 6 months, and 12 months post-operatively.

Study Arms (2)

Control: electrocautery

ACTIVE COMPARATOR

Primary patients with Osteoarthritis (OA) undergoing Total Knee arthroplasty (TKA) will be randomly assigned into either the control or investigational group. The control arm of the study will undergo medial sub periosteal release with electrocautery.

Procedure: Medial Subperiosteal Release with Electrocautery

Investigational: sharp dissection.

ACTIVE COMPARATOR

Primary patients with OA undergoing TKA will be randomly assigned into either the control or investigational group. The investigational arm will undergo medial sub periosteal release using sharp dissection.

Procedure: Medial Subperiosteal Release with Sharp Dissection

Interventions

Medial subperiosteal release - a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) or electrocautery

Also known as: Medial Peel
Investigational: sharp dissection.

Medial subperiosteal release - a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This group will receive this procedure using electrocautery.

Control: electrocautery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over age 18
  • Patients undergoing primary TKA for osteoarthritis

You may not qualify if:

  • Patients undergoing revision TKA
  • Any patients not undergoing TKA for non-OA diagnosis
  • Adults unable to consent
  • Pregnant women
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Orthopaedics and Spine Center

Atlanta, Georgia, 30329, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Electrocoagulation

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

CauteryTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 23, 2021

First Posted

December 10, 2021

Study Start

November 2, 2022

Primary Completion

January 18, 2023

Study Completion

January 18, 2023

Last Updated

October 27, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

At this time it will be an internal study with no sharing of de-identified patient information to third parties.

Locations